Efficacy and Acceptability of Thermal Ablation in the Treatment of Cervical Neoplasia

NACompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

October 17, 2017

Primary Completion Date

August 17, 2020

Study Completion Date

August 17, 2020

Conditions
Cervical Neoplasm
Interventions
PROCEDURE

Treatment of cervical neoplasia by thermal ablation

Women screened for cervical cancer by VIA presenting lesions eligible for ablative treatment were treated by thermal ablation. The treatment consisted in applying the probe on the lesion for 45 seconds at 100 degrees Celsius, with one to up to five applications depending on the lesion size. Following treatment, women were inquired about the pain level during the procedure, their satisfaction level of the procedure and whether they would recommend this treatment to their relatives. Women had a follow-up visit at 6 weeks to assess any complication of the procedure. Women were rescreened at 12 months, to evaluate the cure rate and any long-term adverse events.

Trial Locations (1)

Unknown

Referral Centre of Reproductive Health, Fes

All Listed Sponsors
collaborator

Referral Centre of Reproductive Health, Fez, Morocco

UNKNOWN

collaborator

Referral Centre of Reproductive Health, Taza, Morocco

UNKNOWN

lead

International Agency for Research on Cancer

OTHER

NCT05453318 - Efficacy and Acceptability of Thermal Ablation in the Treatment of Cervical Neoplasia | Biotech Hunter | Biotech Hunter